Global Wound Care Medtech Identifies Growth Opportunities via Robust Due Diligence Assessment

Client Challenge

A global medtech company in wound care solutions sought to evaluate potential growth pathways. They were particularly interested in inorganic growth opportunities within the skin substitutes and soft-tissue reconstruction space.

The client needed a clear understanding of the clinical and commercial positioning of leading skin substitute players, including key differentiation factors and how these targets performed across specialties, procedures, and care settings. They also wanted to identify the risks and opportunities associated with portfolio overlap, cannibalization, and integration.

The client chose Alira Health for an intensive due diligence assessment based on their 20+ years of experience in the wound care space, exclusive access to critical patient data, and extensive clinical and scientific knowledge across various wound care technologies and indications.

Our Approach

Alira Health’s Management Consulting team designed a modular diligence framework to evaluate skin substitute acquisition targets. Through a structured analytical approach, the team assessed product fit by specialty and procedure, evaluating clinical benefits and limitations, future utilization trends, indication expansion potential, key drivers of differentiation, and sources of customer stickiness. Direct benchmarking against leading competitors further clarified each asset’s relative market positioning.

In parallel, Alira Health conducted a directional assessment of strategic portfolio fit and potential commercial synergies between the client and each skin substitute target, providing an integrated perspective to inform acquisition decision-making.

Critical steps:

• Deep alignment on client objectives and key strategic questions, ensuring a clear understanding of the acquisition decision context and success criteria
• Development of primary research program materials informed by these objectives and validated with the client to ensure full alignment prior to fieldwork
• Rapid mobilization and execution of a comprehensive primary research program, including 50 in-depth qualitative interviews and a 100-respondent quantitative survey across the US and select international markets
• Analysis of specialty-level data, procedure volumes, pricing benchmarks, and relevant databases to develop solid estimates of market size, segmentation, and potential upside
• Translation of insights into clear, structured frameworks, enabling focused discussion and validation through regular client touchpoint meetings
• Consolidation of findings into an executive- and board-ready deliverable, designed to directly support acquisition and portfolio decision-making

Outcomes

The approach delivered a clear, customer-validated understanding of target positioning, growth potential, and portfolio integration fit, translating complex clinical and commercial insights into decision-ready guidance to support the client’s acquisition evaluation.

As a result, the client was able to objectively evaluate skin substitute targets, incorporate perspectives from surgeons, procurement representatives, and executives in charge of commercial strategy, to determine portfolio fit and synergies across geographies, with clear, executive-level recommendations.

The client explicitly acknowledged the depth and value added by Alira Health’s work and further demonstrated satisfaction by continued collaboration with Alira Health on related strategic assessments.

Key Success Factors

Alira Health was able to mobilize quickly and reach a large primary research sample within tight timelines, supported by deep expertise in conducting this type of strategic assessment and high flexibility to accommodate evolving client needs.

The team was also able to provide high-quality, real-world insights through targeted engagement with surgeons and other key stakeholders, enabled by Alira Health’s established presence and domain expertise in the wound care space. The findings were translated into actionable strategic guidance that directly supported acquisition and portfolio decision-making.

Alira Health’s approach enabled the client to make a more informed acquisition decision, reducing strategic and integration risk while also identifying value creation levers, strengthening its long-term portfolio leadership in wound care and soft-tissue reconstruction.